Literature DB >> 4395084

Autonomic blocking properties of Wy 21901.

B J Alps, M Hill, E S Johnson, A B Wilson.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 4395084      PMCID: PMC1702655     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.

Authors:  B J Alps; E S Johnson; A B Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

2.  A comparison of the local anaesthetic-, "quinidine-like"- and adrenergic beta-blocking-activities of five beta-receptor antagonists.

Authors:  W G Davis
Journal:  J Pharm Pharmacol       Date:  1970-04       Impact factor: 3.765

3.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
  3 in total
  5 in total

1.  Double-blind trial of indoramin in digital artery disease.

Authors:  P Robson; V Pearce; A C Antcliff; M Hamilton
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

2.  Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.

Authors:  B J Alps; E S Johnson; A B Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

3.  Myocardial effects of indoramin hydrochloride, a new hypotensive agent.

Authors:  D J Coltart; S J Meldrum; R B Royds
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

4.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

5.  Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.

Authors:  V Pierce; N B Shepperson; M H Todd; J F Waterfall
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.